Hammond, Matthew http://orcid.org/0000-0002-0739-3412
Clark, Allan B.
Cahn, Anthony P.
Chilvers, Edwin R.
Fraser, William Duncan
Livermore, David M.
Maher, Toby M.
Parfrey, Helen
Swart, Ann Marie
Stirling, Susan
Thickett, David
Whyte, Moira
Wilson, Andrew
Funding for this research was provided by:
Efficacy and Mechanism Evaluation Programme (12/206/09)
Article History
Received: 7 April 2017
Accepted: 28 December 2017
First Online: 5 February 2018
Ethics approval and consent to participate
: The Surrey Borders Research Ethics Committee (reference 14/LO/1800) has approved the trial at all participating centres. Participant consent is obtained prior to any trial-related procedure. During the consent process it is made clear that the participant can decline to participate in all or any aspect of the trial, at any time and for any reason, without affecting their future care or treatment. Patients unable to provide written informed consent are deemed ineligible for the trial.
: Not applicable.
: The authors of this paper have no financial or other competing interests that impact on their responsibilities towards the scientific value or potential publishing activities associated with the trial.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.